CCM

Camber Capital Management Portfolio holdings

AUM $718M
This Quarter Return
-3.55%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.69B
AUM Growth
+$2.69B
Cap. Flow
+$240M
Cap. Flow %
8.9%
Top 10 Hldgs %
53.13%
Holding
41
New
8
Increased
11
Reduced
8
Closed
4

Top Buys

1
ZBH icon
Zimmer Biomet
ZBH
$106M
2
UHS icon
Universal Health Services
UHS
$93.4M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
$88.9M
4
SRPT icon
Sarepta Therapeutics
SRPT
$46.2M
5
SNY icon
Sanofi
SNY
$36.2M

Top Sells

1
CAH icon
Cardinal Health
CAH
$71.4M
2
SKIN icon
The Beauty Health Co
SKIN
$67.2M
3
ALKS icon
Alkermes
ALKS
$48.6M
4
HOLX icon
Hologic
HOLX
$44.4M
5
TBIO
Translate Bio, Inc. Common Stock
TBIO
$38.6M

Sector Composition

1 Healthcare 96.2%
2 Technology 3.11%
3 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PTCT icon
26
PTC Therapeutics
PTCT
$4.41B
$27.9M 0.86%
+750,000
New +$27.9M
IRTC icon
27
iRhythm Technologies
IRTC
$5.67B
$27.8M 0.86%
+475,000
New +$27.8M
PBYI icon
28
Puma Biotechnology
PBYI
$258M
$24M 0.74%
3,425,000
+700,000
+26% +$4.91M
ZYME icon
29
Zymeworks
ZYME
$1.07B
$21.8M 0.67%
+750,000
New +$21.8M
BIIB icon
30
Biogen
BIIB
$20.8B
$21.2M 0.65%
+75,000
New +$21.2M
RDUS
31
DELISTED
Radius Health, Inc.
RDUS
$18.6M 0.57%
1,500,000
– –
TBPH icon
32
Theravance Biopharma
TBPH
$691M
$18.5M 0.57%
+2,500,000
New +$18.5M
TECX
33
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
$17.5M 0.54%
261,111
– –
INNV icon
34
InnovAge Holding
INNV
$509M
$6.61M 0.2%
1,000,000
-253,000
-20% -$1.67M
AZN icon
35
AstraZeneca
AZN
$255B
– –
0
– –
CAH icon
36
Cardinal Health
CAH
$36B
– –
-1,250,000
Closed -$71.4M
HOLX icon
37
Hologic
HOLX
$14.7B
– –
-665,000
Closed -$44.4M
NVS icon
38
Novartis
NVS
$248B
– –
0
– –
PFE icon
39
Pfizer
PFE
$141B
– –
0
– –
SKIN icon
40
The Beauty Health Co
SKIN
$254M
– –
-4,000,000
Closed -$67.2M
TBIO
41
DELISTED
Translate Bio, Inc. Common Stock
TBIO
– –
-1,400,000
Closed -$38.6M
1
2